Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-19-012935
Filing Date
2019-07-17
Accepted
2019-07-17 06:44:09
Documents
9
Period of Report
2019-07-17

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k071719_immuronlimited.htm 6-K 24427
2 PROPOSED PUBLIC OFFER OF IMRN ADSS f6k071719ex99-1_immuron.htm EX-99.1 13753
3 IMMURON PRICES UNDERWRITTEN PUBLIC OFFERING OF ADSS" f6k071719ex99-2_immuron.htm EX-99.2 17294
4 IMMURON TO HOST INVESTOR WEBINAR f6k071719ex99-3_immuron.htm EX-99.3 18428
5 GRAPHIC ex99-1_001.jpg GRAPHIC 19105
6 GRAPHIC ex99-2_001.jpg GRAPHIC 19105
7 GRAPHIC ex99-3_001.jpg GRAPHIC 17725
8 GRAPHIC ex99-3_002.jpg GRAPHIC 20817
9 GRAPHIC ex99-3_003.jpg GRAPHIC 10514
  Complete submission text file 0001213900-19-012935.txt   195814
Mailing Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053
Business Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-38104 | Film No.: 19958199
SIC: 2834 Pharmaceutical Preparations